About: Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
Creator	Conti, Clara Grassia, Roberto Soro, Sara
Source	Medline; PMC
abstract	covid:c81c670841d2b21ec49481d92681dccb9c3b52bf#abstract
has issue date	2020-05-09(xsd:dateTime)
bibo:doi	10.1093/ibd/izaa110
bibo:pmid	32386056
has license	no-cc
sha1sum (hex)	c81c670841d2b21ec49481d92681dccb9c3b52bf
schema:url	https://doi.org/10.1093/ibd/izaa110
resource representing a document's title	Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
has PubMed Central identifier	PMC7239122
has PubMed identifier	32386056
schema:publication	Inflamm Bowel Dis
resource representing a document's body	covid:c81c670841d2b21ec49481d92681dccb9c3b52bf#body_text
is schema:about of	named entity 'mechanism of action' named entity 'interferon-γ' named entity 'angiotensin-converting enzyme 2' named entity 'IBD' named entity 'SARS-CoV-2' named entity 'observational study' named entity 'mucosal' named entity 'cytokines' named entity 'IBD' named entity 'IBD' named entity 'severe pneumonia' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'China' named entity 'IL-6 receptor' named entity 'immunosuppressive' named entity 'IBD' named entity 'cytokine storm' named entity 'inflammatory bowel disease' named entity 'IBD' named entity 'COVID' named entity 'ACE2' named entity 'Italy' named entity 'IBD' named entity 'necrosis' named entity 'pneumonia' named entity 'inflammation' named entity 'IL-6' named entity 'COVID' named entity 'Italian' named entity 'ustekinumab' named entity 'vedolizumab' named entity 'IBD' named entity 'azathioprine' named entity 'inflammatory response' named entity 'immunosuppressive therapy' named entity 'upregulated' named entity 'SARS-CoV-2' named entity 'ulcerative colitis' named entity 'Crohn's disease' named entity 'coronavirus' named entity 'ACE2' named entity 'pneumonia' named entity 'TNF' named entity 'province of Cremona' named entity 'Wuhan' named entity 'chronic diseases' named entity 'SARS-Cov-2' named entity 'COVID' named entity 'COVID' named entity 'antitumor' named entity 'IBD' named entity 'COVID-19' named entity 'COVID' named entity 'IBD' named entity 'biological therapy' named entity 'COVID' named entity 'ACE2' named entity 'relapse' named entity 'tocilizumab' named entity 'interleukin (IL)-2' named entity 'TNFα' named entity 'COVID' named entity 'IBD' named entity 'Inflammatory Bowel Diseases' named entity 'SARS-CoV-2' named entity 'Biological' named entity 'Why Not' named entity 'Bowel' named entity 'SARS-CoV-2' named entity 'Diseases' named entity 'Inflammatory' named entity 'Era' named entity 'ERA' named entity 'INFLAMMATORY BOWEL DISEASES' named entity 'BIOLOGICAL TREATMENT' named entity 'SARS-COV-2' named entity 'WHY'
is part of of	covid:c81c670841d2b21ec49481d92681dccb9c3b52bf#abstract

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software